Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of PNH Read more
ImmunoPrecise’s Talem Therapeutics Enters into an LOI with AgonOx Pharma in the Advancement of Novel, Immuno-Oncology Therapeutics Read more
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia Read more
Aldeyra Therapeutics Receives Fast Track Designation for ADX-2191 for the Prevention of Proliferative Vitreoretinopathy Read more
Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of RWE in Oncology Read more
Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas Read more
NeuCyte Licenses Promising Novel Compound for Treatment of Refractory Epilepsy and Related Neurological Disorders Read more
Catalent And Minerva Neurosciences Enter Commercial Supply Agreement For Schizophrenia Drug Roluperidone Read more